Lucid Laboratories Private LimitedMarch 8, 2024

FDA 483 - Lucid Laboratories Private Limited - March 08, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Lucid Laboratories Private Limited

Record Details

An FDA inspection of Lucid Laboratories Private Limited, a control testing laboratory in Hyderabad, India, from March 6-8, 2024, revealed significant deficiencies in its quality control unit. The firm failed to follow written procedures for documenting standards lists and deviated from specified test method parameters, including injection volumes, without notifying customers. These issues indicate a lack of adherence to established quality control processes.

Company: Lucid Laboratories Private Limited
Inspection Date: March 8, 2024
Product Type: Drugs
Office: Office of Partnerships
Person: Nicole E. Knowlton (Investigator )

Open in Dashboard

ID · 8a65232b-a490-42c3-aced-2e66248d68f7